127 related articles for article (PubMed ID: 10582211)
1. [Prevention of Lyme disease].
Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
Med Pr; 1999; 50(4):321-4. PubMed ID: 10582211
[TBL] [Abstract][Full Text] [Related]
2. [Lyme disease vaccine: hopes and concerns].
Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
Pol Merkur Lekarski; 1999 Jun; 6(36):344-6. PubMed ID: 10481552
[TBL] [Abstract][Full Text] [Related]
3. ACIP issues recommendations for Lyme disease vaccine. Advisory Committee on Immunization Practices.
Morey SS
Am Fam Physician; 1999 Nov; 60(7):2171-2. PubMed ID: 10569515
[No Abstract] [Full Text] [Related]
4. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.
Steere AC; Sikand VK; Meurice F; Parenti DL; Fikrig E; Schoen RT; Nowakowski J; Schmid CH; Laukamp S; Buscarino C; Krause DS
N Engl J Med; 1998 Jul; 339(4):209-15. PubMed ID: 9673298
[TBL] [Abstract][Full Text] [Related]
5. Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or both.
Luke CJ; Marshall MA; Zahradnik JM; Bybel M; Menefee BE; Barbour AG
J Infect Dis; 2000 Mar; 181(3):1062-8. PubMed ID: 10720532
[TBL] [Abstract][Full Text] [Related]
6. Availability of Lyme disease vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 Jan; 48(2):35-6, 43. PubMed ID: 9933128
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Lyme disease.
Med Lett Drugs Ther; 2000 May; 42(1077):37-9. PubMed ID: 10825919
[No Abstract] [Full Text] [Related]
8. Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old.
Beran J; De Clercq N; Dieussaert I; Van Hoecke C
Clin Infect Dis; 2000 Dec; 31(6):1504-7. PubMed ID: 11096024
[TBL] [Abstract][Full Text] [Related]
9. [Lyme borreliosis--vaccines in the "pipeline"].
Kramer M
MMW Fortschr Med; 1999 Jun; 141(25):52-3. PubMed ID: 10897909
[No Abstract] [Full Text] [Related]
10. Adjuvanted Lyme disease vaccine: a review of its use in the management of Lyme disease.
Onrust SV; Goa KL
Drugs; 2000 Feb; 59(2):281-99. PubMed ID: 10730551
[TBL] [Abstract][Full Text] [Related]
11. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
Molloy PJ; Berardi VP; Persing DH; Sigal LH
Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
[TBL] [Abstract][Full Text] [Related]
12. First human vaccine for Lyme disease.
Ramani A
Mayo Clin Proc; 1999 Aug; 74(8):846-7. PubMed ID: 10473370
[No Abstract] [Full Text] [Related]
13. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
14. Keeping Lyme disease at bay. An integrated approach to prevention.
Wade CF
Am J Nurs; 2000 Jul; 100(7):26-31; quiz 32. PubMed ID: 10914066
[No Abstract] [Full Text] [Related]
15. Arthritis following recombinant outer surface protein A vaccination for Lyme disease.
Rosé CD; Fawcett PT; Gibney KM
J Rheumatol; 2001 Nov; 28(11):2555-7. PubMed ID: 11708435
[TBL] [Abstract][Full Text] [Related]
16. Lyme disease and the Lyme disease vaccines.
Sigal LH
Bull Rheum Dis; 1999 Apr; 48(4):1-4. PubMed ID: 10418202
[TBL] [Abstract][Full Text] [Related]
17. Protection from Lyme neuroborreliosis in nonhuman primates with a multiantigenic vaccine.
Pachner AR; Delaney E; Zhang WF; O'Neill T; Major E; Frey AB; Davidson E
Clin Immunol; 1999 Jun; 91(3):310-3. PubMed ID: 10370376
[TBL] [Abstract][Full Text] [Related]
18. Lyme vaccine enhancement. N-terminal acylation of a protein antigen and inclusion of a saponin adjuvant.
Coughlin RT; Ma J; Cox DE
Pharm Biotechnol; 1995; 6():719-35. PubMed ID: 7551245
[No Abstract] [Full Text] [Related]
19. Progress and controversy surrounding vaccines against Lyme disease.
Hanson MS; Edelman R
Expert Rev Vaccines; 2003 Oct; 2(5):683-703. PubMed ID: 14711329
[TBL] [Abstract][Full Text] [Related]
20. Lyme disease vaccine safe for all?
Rahn DW
Postgrad Med; 1999 Jun; 105(7):21. PubMed ID: 10376044
[No Abstract] [Full Text] [Related]
[Next] [New Search]
